Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.660,59
0,52%
NASDAQ
18.488,42
0,09%
Bitcoin
65.172,92
0,50%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Blueprint Medicines Corporation (BPMC) Blueprint Medicines Corporation (BPMC) Notizie

BPMC

Blueprint Medicines (BPMC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC
DataOraFonteTitoloSimboloCompagnia
05/04/201614:00PR Newswire (US)Blueprint Medicines to Present at 15th Annual Needham Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
28/03/201623:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
28/03/201623:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:BPMCBlueprint Medicines Corporation
28/03/201622:04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BPMCBlueprint Medicines Corporation
18/03/201621:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
17/03/201613:00PR Newswire (US)Blueprint Medicines to Present Preclinical Data on RET Inhibitors in an Oral Presentation at American Association for Cancer ...NASDAQ:BPMCBlueprint Medicines Corporation
15/03/201612:00PR Newswire (US)Blueprint Medicines Announces Worldwide Collaboration to Accelerate and Expand its Development of Novel Medicines in the Fiel...NASDAQ:BPMCBlueprint Medicines Corporation
11/03/201614:05PR Newswire (US)Blueprint Medicines Reports Fourth Quarter and Full Year 2015 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
02/03/201614:05PR Newswire (US)Blueprint Medicines to Present at Cowen and Company 36th Annual Health Care ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
16/02/201622:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BPMCBlueprint Medicines Corporation
16/02/201614:00PR Newswire (US)Blueprint Medicines to Present at RBC Capital Markets 2016 Global Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
05/02/201622:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BPMCBlueprint Medicines Corporation
04/02/201622:05PR Newswire (US)Blueprint Medicines Appoints Lonnel Coats to Board of DirectorsNASDAQ:BPMCBlueprint Medicines Corporation
05/01/201622:05PR Newswire (US)Blueprint Medicines Strengthens Executive Leadership TeamNASDAQ:BPMCBlueprint Medicines Corporation
17/12/201522:05PR Newswire (US)Blueprint Medicines Added to NASDAQ Biotechnology IndexNASDAQ:BPMCBlueprint Medicines Corporation
01/12/201514:00PR Newswire (US)Blueprint Medicines and PatientCrossroads Launch Registry for Mastocytosis Patients to Increase Understanding of Disease and ...NASDAQ:BPMCBlueprint Medicines Corporation
12/11/201514:30PR Newswire (US)Blueprint Medicines to Present Preclinical Data at 2015 ASH Annual Meeting Demonstrating Anti-tumor Activity of BLU-285 in a ...NASDAQ:BPMCBlueprint Medicines Corporation
09/11/201523:40Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BPMCBlueprint Medicines Corporation
09/11/201522:15PR Newswire (US)Blueprint Medicines Highlights Advances in Preclinical Discovery EffortsNASDAQ:BPMCBlueprint Medicines Corporation
09/11/201522:01PR Newswire (US)Blueprint Medicines Reports Third Quarter 2015 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
30/09/201514:00PR Newswire (US)Blueprint Medicines Receives FDA Orphan Drug Designation for Novel Drug Candidate for Treatment of Hepatocellular CarcinomaNASDAQ:BPMCBlueprint Medicines Corporation
10/09/201514:00PR Newswire (US)Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic MastocytosisNASDAQ:BPMCBlueprint Medicines Corporation
03/09/201514:00PR Newswire (US)Blueprint Medicines to Present at the 22nd Annual NewsMakers in the Biotech Industry ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
01/09/201514:00PR Newswire (US)Blueprint Medicines to Present Preclinical Data on BLU-554 and on Novel Drug Target at International Liver Cancer Association...NASDAQ:BPMCBlueprint Medicines Corporation
10/08/201523:01PR Newswire (US)Blueprint Medicines Reports Second Quarter 2015 Financial Results and Provides Business UpdateNASDAQ:BPMCBlueprint Medicines Corporation
04/08/201514:00PR Newswire (US)Blueprint Medicines to Present at 2015 Wedbush PacGrow Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
13/07/201514:05PR Newswire (US)Blueprint Medicines Receives FDA Authorization to Proceed with Clinical Trials for Two Drug CandidatesNASDAQ:BPMCBlueprint Medicines Corporation
29/06/201514:00PR Newswire (US)Blueprint Medicines Added to Russell 2000®, 3000® and Global IndexesNASDAQ:BPMCBlueprint Medicines Corporation
11/06/201522:05PR Newswire (US)Blueprint Medicines Reports First Quarter 2015 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
05/06/201514:30PR Newswire (US)Blueprint Medicines to Present at Upcoming Investor Conferences in JuneNASDAQ:BPMCBlueprint Medicines Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC

La tua Cronologia

LSE
0M6I
Koninklijke Heijmans N.v
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network